Teladoc Health Q1 Earnings Miss Estimates, Revenue Falls Short

Tiger Newspress
Apr 30

Teladoc Health reported first-quarter 2026 results after the closing bell on Tuesday, with earnings and revenue coming in shy of analyst expectations. The market reacted swiftly, with shares falling over 11% in after-hours trading.

The virtual care company posted revenue of $613.8 million for the three months ended March 31, 2026, a 2% decline from the $629.4 million reported in the same period last year. Analysts had been looking for revenue closer to $623.1 million, meaning the headline number missed by roughly $9.3 million.

Earnings per share came in at a net loss of $0.36 on a GAAP basis, which was wider than the consensus estimate of a $0.32 loss per share. While the net loss improved from the $93.0 million loss recorded in Q1 2025, that year-ago figure had been inflated by a $59.1 million goodwill impairment charge that did not repeat in the current quarter.

Adjusted EBITDA of $58.2 million was essentially flat year-over-year and came in within the company's guided range, though the metric failed to provide a positive surprise.

Segment Performance and Key Metrics

The results revealed a clear divergence between Teladoc's two operating segments.

  • Integrated Care: Revenue grew 2% to $395.4 million, with adjusted EBITDA margin expanding to 14.2% from 12.9% in the prior year. This segment remains the more stable part of the business.

  • BetterHelp: Revenue declined 9% to $218.4 million, as average paying users dropped 9% to 361,000 from 397,000 a year ago. Adjusted EBITDA margin tumbled to just 0.9%, down from 3.2%. The company noted it is making progress scaling insurance acceptance within this direct-to-consumer mental health platform, but the numbers suggest the transition is still cost-intensive.

Total visits across the platform were flat at 4.4 million. U.S. Integrated Care members slipped 1% to 101.2 million, though average monthly revenue per member ticked up 2% to $1.30.

Cash flow from operations totaled $9.5 million, down from $15.9 million in the year-ago quarter, while capital expenditures and capitalized software development costs pushed free cash flow to a negative $26.3 million.

Outlook Holds the Midpoint, But Near-Term Pressure Remains

Teladoc management reaffirmed the midpoint of its full-year 2026 guidance, which it had originally provided in February. The full-year outlook calls for:

  • Revenue in the range of $2.481 billion to $2.576 billion

  • Adjusted EBITDA between $267 million and $306 million

  • Net loss per share of ($1.05) to ($0.75)

  • Free cash flow of $130 million to $170 million

For the second quarter of 2026, management projected revenue of $597 million to $626 million and adjusted EBITDA of $55 million to $67 million.

The midpoint of the Q2 revenue outlook ($611.5 million) is roughly in line with current analyst estimates of $637.3 million, though the low end of the range suggests management is hedging against continued headwinds in the BetterHelp segment. The Q2 adjusted EBITDA midpoint of $61 million appears broadly consistent with street expectations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10